1 |
何 巧. 肺纤维化机制的研究进展[J]. 重庆医学,2019, 48(20): 3553-3557.
|
2 |
王在强,傅恩清. 调节性T细胞在肺纤维化中作用的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 237-240.
|
3 |
Yao C, Guan X, Carraro G, et al. Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis[J]. Am J Respir Crit Care Med, 2021, 203(6): 707-717.
|
4 |
Phan T, Paliogiannis P, Nasrallah GK, et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis[J]. Cell Mol Life Sci, 2021, 78(5): 2031-2057.
|
5 |
Zhang Y, Lu P, Qin H, et al. Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential[J]. Biomed Pharmacother, 2021, 133: 111072.
|
6 |
Bahri S, Ben AR, Gasmi K, et al. Prophylactic and curative effect of rosemary leaves extract in a bleomycin model of pulmonary fibrosis[J]. Pharm Biol, 2017, 55(1): 462-471.
|
7 |
de Oliveira JR, Camargo S, de Oliveira LD. Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent[J]. J Biomed Sci, 2019, 26(1): 5.
|
8 |
Zappala A, Vicario N, Calabrese G, et al. Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells[J]. Nat Prod Res, 2021, 35(4): 669-675.
|
9 |
Alavi MS, Fanoudi S, Ghasemzadeh RM, et al. An updated review of protective effects of rosemary and its active constituents against natural and chemical toxicities[J]. Phytother Res, 2021, 35(3): 1313-1328.
|
10 |
Otoupalova E, Smith S, Cheng G, et al. Oxidative stress in pulmonary fibrosis[J]. Compr Physiol, 2020, 10(2): 509-547.
|
11 |
潘 玲,卢岳虹,宋 策,等. 银杏叶提取物治疗肺纤维化的作用机制[J]. 中国现代医学杂志,2020, 30(6): 57-61.
|
12 |
张 鑫,唐其柱,马振国,等. 迷迭香酸对H9C2心肌细胞氧化应激损伤的影响[J]. 中华生物医学工程杂志,2017, 23(6): 446-452.
|
13 |
Hamed H, Boulila S, Ghrab F, et al. The preventive effect of aqueous extract of Rosemary (Rosmarinus officinalis) leaves against the nephrotoxicity of carbon tetrachloride in mice[J]. Arch Physiol Biochem, 2020, 126(3): 201-208.
|
14 |
星 萍,陈晓平,邢钰彬,等. 紫苏迷迭香酸对D-半乳糖衰老模型小鼠的抗氧化作用[J]. 食品科技,2021,46(4): 222-227.
|
15 |
梁正敏,廖晓光,文雪梅,等. 迷迭香酸对哮喘小鼠氧化性肺损伤的保护作用[J]. 中国畜牧兽医,2017,44(12):3650-3655.
|
16 |
Wang L, Li S, Yao Y, et al. The role of natural products in the prevention and treatment of pulmonary fibrosis: a review[J]. Food Funct, 2021,12(3):990-1007.
|
17 |
陈 星,童德银,贾增永,等. 芪术肺纤汤对特发性肺间质纤维化患者肺功能、血清TGF-β以及TNF-α因子影响分析[J]. 临床和实验医学杂志,2021, 20(1): 25-28.
|
18 |
Phan T, Paliogiannis P, Nasrallah GK, et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis[J]. Cell Mol Life Sci, 2021, 78(5): 2031-2057.
|
19 |
郭玉娟,李瑞,颜天华. 肺纤维化的相关机制及研究进展[J]. 西北药学杂志,2020, 35(4): 624-629.
|
20 |
颜春鲁,安方玉,刘永琦,等. 泻肺汤对肺纤维化模型大鼠炎症因子及VEGF蛋白表达的影响[J]. 北京中医药大学学报,2019, 42(10): 847-853.
|
21 |
王丽娜,罗 竹,黄小朵,等. 黄芪-丹参药对对特发性肺纤维化小鼠肺泡炎症及纤维化的影响[J]. 中成药,2020, 42(6): 1600-1604.
|
22 |
Kalantar H, Sadeghi E, Abolnezhadian F, et al. Carnosol attenuates bleomycin-induced lung damage via suppressing fibr1osis, oxidative stress and inflammation in rats[J]. Life Sci, 2021, 287: 120059.
|
23 |
阮仁余,邓祥敏,朱星宇,等. 鼠尾草酸对类风湿关节炎大鼠NF-κB信号通路的影响研究[J]. 现代中西医结合杂志,2020, 29(25): 2757-2761.
|
24 |
Yousef M, Crozier R, Hicks NJ, et al. Attenuation of allergen-mediated mast cell activation by rosemary extract (Rosmarinus officinalis L.)[J]. J Leukoc Biol, 2020, 107(5): 843-857.
|
25 |
刘 建,王 玥,王玉光. 特发性肺纤维化发病机制及药物研究新进展[J]. 医学综述,2020, 26(11): 2111-2116.
|
26 |
杨伟强,赵 峰. 特发性肺纤维化发病机制的研究进展[J]. 医学综述,2020, 26(9): 1684-1689, 1695.
|
27 |
Cin B, Ciloglu NS, Omar S, et al. Effect of rosmarinic acid and alcohol on fat graft survival in rat model[J]. Aesthetic Plast Surg, 2020, 44(1): 177-185.
|
28 |
Zhang T, Ma S, Liu C, et al. Rosmarinic acid prevents radiation-induced pulmonary fibrosis through attenuation of ROS/MYPT1/TGFbeta1 signaling via miR-19b-3p[J]. Dose Response, 2020, 18(4): 710550051.
|
29 |
杨礼腾,刘 欣,程德云,等. 迷迭香二萜芬提取物对肺纤维化大鼠肺组织TGF-β1及其信号通路分子mRNA表达的影响[J]. 中国中西医结合杂志,2013, 33(6): 819-824.
|
30 |
Zhang M, Zhang S. T Cells in Fibrosis and Fibrotic Diseases[J]. Front Immunol, 2020, 11: 1142.
|
31 |
肖 雪,李 龙. 基质金属蛋白酶与特发性肺纤维化关系研究进展[J]. 河北医药,2020, 42(22): 3462-3467.
|
32 |
刘 锐,何 嘉,梁梓扬,等. 麦门冬汤对肺纤维化模型大鼠肺组织转化生长因子β1和基质金属蛋白酶9及基质金属蛋白酶组织抑制剂1表达的影响研究[J]. 中国全科医学,2018, 21(29): 3590-3596.
|
33 |
高 瑕. 甘草酸制剂防治肺纤维化的研究进展[J]. 西北国防医学杂志,2020, 41(11): 718-723.
|
34 |
Chae IG, Yu MH, Im NK, et al. Effect of Rosemarinus officinalis L. on MMP-9, MCP-1 levels, and cell migration in RAW 264.7 and smooth muscle cells[J]. J Med Food, 2012, 15(10): 879-886.
|
35 |
Huang SC, Ho CT, Lin-Shiau SY, et al. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun[J]. Biochem Pharmacol, 2005, 69(2): 221-232.
|
36 |
Hoskin R, Pambianchi E, Pecorelli A, et al. Novel spray dried algae-rosemary particles attenuate pollution-induced skin damage[J]. Molecules, 2021, 26(13): 3781.
|
37 |
孙 佳,张广平,李 晗,等. 肺纤维化发病机制的研究进展[J]. 国际呼吸杂志,2019, 39(13): 1004-1008.
|
38 |
李 洪,王昌明. 肺纤维化发病机制的研究进展[J]. 广西医学,2018, 40(19): 2325-2327, 2331.
|
39 |
Bahri S, Mies F, Ben AR, et al. Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts[J]. PLoS One, 2017, 12(9): e184368.
|
40 |
Theoduloz C, Pertino MW, Rodriguez JA, et al. Gastroprotective effect and cytotoxicity of carnosic acid derivatives[J]. Planta Med, 2011, 77(9): 882-887.
|
41 |
Bahri S, Ali RB, Abdennabi R, et al. Industrial elimination of essential oils from rosmarinus officinalis: In support of the synergic antifibrotic effect of rosmarinic and carnosic acids in bleomycin model of lung fibrosis[J]. Nutr Cancer, 2020: 1-12.
|
42 |
Pan T, Zhou Q, Miao K, et al. Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis[J]. Theranostics, 2021, 11(3): 1192-1206.
|
43 |
王 莹,邓 慧,曾祥辉,等. 中药迷迭香提取物的临床应用研究概述[J]. 今日药学,2021, 31(7): 497-500.
|